Target intelligence / Profile preview

Haemophilus influenzae type b polysaccharide conjugate antigen (None)

Target: None
Molecular classification: Polysaccharide, Conjugate Vaccine, Antigen

Overview

The Haemophilus influenzae type b (Hib) polysaccharide conjugate antigen is the active component in Hib conjugate vaccines, designed to prevent invasive diseases caused by *Haemophilus influenzae* type b bacteria. It consists of the Hib capsular polysaccharide PRP conjugated to a carrier protein to enhance immunogenicity in infants and young children, eliciting a T-cell dependent immune response and long-lasting protection.

Other names: Hib polysaccharide conjugate antigenPRP conjugate vaccinePolyribosyl-ribitol-phosphate conjugateHib vaccine antigen

Mechanism of action

Induces anti-PRP antibodies via a T-cell dependent immune response, leading to opsonization and complement-mediated killing of *Haemophilus influenzae* type b bacteria.

Biological functions

Immune response inductionAntibody productionImmunological memory formationPrevention of bacterial infection

Disease associations

InfectionHaemophilus influenzae type b infectionsMeningitisPneumoniaEpiglottitisSeptic arthritisPericarditisSepsis

Safety considerations

Local injection site reactionsFeverRare allergic reactions

Interacting drugs

Hiberix

3 more in the full profile.

Biomarkers

Anti-PRP antibody titersIgG levels

Beyond the preview

Go deeper on Haemophilus influenzae type b polysaccharide conjugate antigen (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Haemophilus influenzae type b polysaccharide conjugate antigen (None).

Explore the full profile